Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 3

Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NCT06851754

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 11–19 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Phase 3
Target enrollment
185
US sites recruiting
1
Study start
July 17, 2025
Record last updated
October 21, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Background

Premature ovarian insufficiency (POI) is a condition in which women under the age of 40 years have absent or irregular menstrual cycles. POI can cause infertility, signs of menopause, osteoporosis, and other symptoms. Hormone replacement therapy (HRT) is a treatment that gives women extra hormones, such as estrogen and progesterone. HRT works well in adult women. Researchers want to find the most effective doses and regimens for adolescents.

Objective

To monitor the effects of HRT on adolescents with POI.

Eligibility

Female adolescents aged 11 to 19 years diagnosed with POI. Healthy volunteers are also needed.

Design

All participants will have clinic visits every 6 months for 2 years. Each visit may last 2 days. Each visit may include:

Blood and urine tests.

A test of their heart function.

A test to measure the stiffness of their blood vessels. Participants will lie flat with a blood pressure cuff on a leg and a meter on the neck while the cuff inflates.

A test of their grip strength. Participants will squeeze a handheld device as hard as they can.

Two scans to measure bone density. For one, participants will lie on a table while a scanner passes along their body. For the other, participants will sit in a chair and insert their forearm, then their lower leg, into a scanner.

A test to measure skin pigmentation. Participants' skin will be touched lightly with a device.

An optional visual exam of the vagina. Some vaginal fluid may also be collected with a cotton swab/cytobrush.

Participants with POI will receive HRT. They will be given estrogen patches and progesterone pills.

Being studied: Progesterone; Estrogen Patch

Conditions: Premature Ovarian Insufficiency

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria
  • INCLUSION CRITERIA:

Inclusion Criteria for POI Participants

To be eligible to participate in this study, an individual must meet all the following criteria:

  • Individuals aged 11-19 years, inclusive, at the time of enrollment.
  • Diagnosis of premature ovarian insufficiency.
  • Documentation of one elevated serum FSH measurement greater than the testing laboratory's upper reference range (for age/Tanner stage).
  • Identify as female (i.e., sex assigned at birth)
  • Negative pregnancy test.

Inclusion Criteria for Healthy Volunteers

  • Individuals aged 11-19 years.
  • Identify as female (i.e., sex assigned at birth)
  • Negative pregnancy test.
  • Absence of known chronic disease

EXCLUSION CRITERIA

Male participants are excluded from both study groups (POI and Healthy Volunteers) as POI affects only the female reproductive system, while pregnant participants are not eligible to have DXA or HRpQCT imaging for safety reasons.

Exclusion Criteria for POI participants

An individual who meets any of the following criteria will be excluded from participation in this study:

  • POI in the setting of Turner syndrome.
  • Patients who screened positive for celiac disease.
  • Receipt of any medications including HRT determined by the investigator to affect bone metabolism 3 months prior to enrollment.
  • Any medical condition determined by the investigator to affect bone health will be excluded.
  • Presence of a medical, psychiatric, or social condition which, in the opinion of the investigator, would place undue burden on the subject, NIH resources, or increase risk of participation.
  • Report of sexual activity but refusal to use a copper intrauterine device or double barrier forms of contraception during the study.

Exclusion Criteria for Healthy Volunteers

For healthy volunteers, all exclusion criteria will apply as for POI participants except for number 1.

Recruiting US locations

  • National Institutes of Health Clinical Center

    Bethesda, MD 20892

    Site contact: NIH Clinical Center Office of Patient Recruitment (OPR) · 800-411-1222 · ccopr@nih.gov

Study contacts (from the official record)

  • Catherine M Gordon, M.D. · (301) 827-5449 · catherine.gordon@nih.gov
Hormone Replacement Therapy in Adolescents With Premature Ovarian… (NCT06851754) | Bored Studies